- Advertisement -
Saturday, March 25, 2023

News

The market for outsourced biologics manufacturing is expected to reach $34.1 billion by the end of 2033

Contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) are biotechnology firms that offer a variety of services to pharmaceutical and biotechnology...

Medical professionalism in a changing world

Human life was transitory before the discovery of modern medicine. Unseen risks in the form of sickness and medical disorders abound in the environment....

Creating More Parity Across a Tilted Healthcare Picture

Human beings are known for a myriad of different things, but most notably, they are known for getting better on a consistent basis. This...

Turning the Attention to an Underserved Segment

Surely, the human arsenal is expansive beyond all limits, but it still doesn’t have anything more valuable than tendency of ours to grow on...

Ekso Bionics Acquires Parker Hannifin’s Business Unit; Expands Product Offering across the Continuum of Care to Home and Community use Markets

There is no end to what all human beings can do, but there is little we do better than growing on a consistent basis....

Constructing a Convenient Healthcare Experience

Human beings are known for a myriad of different things, but most importantly, they are known for getting better on a consistent basis. This...

Disrupting the Pharmaceutical Space Like Never Before

The human arsenal has a lot more to it than we usually acknowledge, and yet it doesn’t boast a feature more valuable than that...

Weaving a More Informed Healthcare Space

The human arsenal is known for a myriad of different things, but most importantly, it is known for getting better on a consistent basis....

Addressing a Big Old Plague

While the human arsenal has proven itself to be pretty much limitless, it still doesn’t possess anything more valuable than that tendency of ours...
- Advertisement -

Editor Picks

Course Director BSc (Hons) Diagnostic Radiography and Imaging

Until relatively recently, vision had been considered an attribute of animates only.  The ImageNet challenge provided a showcase for artificial intelligence (AI) tools for...

Powering Diverse and Inclusive Clinical Trials

The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving diversity among clinical trial participants. While...

Improving antibiotic use with novel diagnostic technologies: Challenges Ahead

Antibiotics have revolutionized human medicine in the twentieth century. Deadly diseases such as streptococcal pneumonia or gangrene became curable, and also other advances of...

The power of novel excipients in 505(b)(2) products

The FDA 505(b)(2) regulatory pathway for drug approval, which allows applicants to use existing safety data as evidence, continues to grow in popularity. Innovators...

Where Is Pharma Headed in 2023?

Learn 10 disruptive trends shaping the future of life science manufacturing, and how you can adapt to stay on target and ahead of the...

Industry Pros Come Together to Develop ASTM Protocols

A powerhouse group was created with the goal of getting ASTM to adopt standards for SIJ fusion devices. Accurate, repeatable, and reproducible—that’s the mantra we’ve...